Mogens Schou

9.8k total citations · 3 hit papers
177 papers, 6.6k citations indexed

About

Mogens Schou is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mogens Schou has authored 177 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Psychiatry and Mental health, 16 papers in Pediatrics, Perinatology and Child Health and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mogens Schou's work include Bipolar Disorder and Treatment (98 papers), Schizophrenia research and treatment (15 papers) and Electrolyte and hormonal disorders (14 papers). Mogens Schou is often cited by papers focused on Bipolar Disorder and Treatment (98 papers), Schizophrenia research and treatment (15 papers) and Electrolyte and hormonal disorders (14 papers). Mogens Schou collaborates with scholars based in Denmark, Slovenia and United States. Mogens Schou's co-authors include A. Amdisen, Klaus Thomsen, Per Vestergaard, P. C. Baastrup, Erik Strömgren, N Juel-Nielsen, Paul Grof, Jens-Christian N. Poulsen, Jules Angst and Paola Souza Castro Weis and has published in prestigious journals such as Nature, The Lancet and JAMA.

In The Last Decade

Mogens Schou

167 papers receiving 5.5k citations

Hit Papers

Lithium in psychiatric therapy and prophylaxis 1954 2026 1978 2002 1968 1970 1954 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mogens Schou Denmark 42 4.2k 1.2k 868 848 796 177 6.6k
Kirk D. Denicoff United States 47 6.4k 1.5× 797 0.7× 470 0.5× 411 0.5× 1.6k 2.1× 74 8.5k
Alec Coppen United Kingdom 54 3.7k 0.9× 558 0.5× 401 0.5× 1.1k 1.3× 1.1k 1.4× 219 9.8k
John A. Ascher United States 32 3.1k 0.8× 781 0.7× 267 0.3× 658 0.8× 710 0.9× 60 6.1k
B. Müller‐Oerlinghausen Germany 42 4.1k 1.0× 804 0.7× 207 0.2× 526 0.6× 1.3k 1.6× 262 6.5k
Paul Grof Canada 43 5.0k 1.2× 407 0.3× 309 0.4× 495 0.6× 1.5k 1.9× 198 6.5k
Heinz Grunze Germany 57 9.8k 2.4× 1.3k 1.1× 486 0.6× 653 0.8× 2.1k 2.7× 299 12.6k
Michael Gitlin United States 49 5.5k 1.3× 557 0.5× 265 0.3× 375 0.4× 2.3k 2.8× 151 8.3k
Janusz Rybakowski Poland 53 5.9k 1.4× 594 0.5× 474 0.5× 1.2k 1.4× 1.6k 2.0× 466 11.3k
Russell T. Joffe Canada 53 3.6k 0.9× 543 0.5× 205 0.2× 405 0.5× 2.5k 3.1× 210 9.1k
A. Amdisen Denmark 26 1.9k 0.5× 706 0.6× 680 0.8× 343 0.4× 205 0.3× 78 2.9k

Countries citing papers authored by Mogens Schou

Since Specialization
Citations

This map shows the geographic impact of Mogens Schou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mogens Schou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mogens Schou more than expected).

Fields of papers citing papers by Mogens Schou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mogens Schou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mogens Schou. The network helps show where Mogens Schou may publish in the future.

Co-authorship network of co-authors of Mogens Schou

This figure shows the co-authorship network connecting the top 25 collaborators of Mogens Schou. A scholar is included among the top collaborators of Mogens Schou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mogens Schou. Mogens Schou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomsen, Klaus & Mogens Schou. (1999). Avoidance of Lithium Intoxication: Advice Based on Knowledge about the Renal Lithium Clearance under Various Circumstances. Pharmacopsychiatry. 32(3). 83–86. 26 indexed citations
2.
Schou, Mogens. (1998). Treating Recurrent Affective Disorders During and After Pregnancy. Drug Safety. 18(2). 143–152. 31 indexed citations
3.
Schou, Mogens. (1997). The combat of non‐compliance during prophylactic lithium treatment. Acta Psychiatrica Scandinavica. 95(5). 361–363. 53 indexed citations
4.
Schou, Mogens. (1995). Prophylactic Lithium Treatment of Unipolar and Bipolar Manic-Depressive Illness. Psychopathology. 28(1). 81–85. 5 indexed citations
5.
Ahrens, B., B. Müller‐Oerlinghausen, Mogens Schou, et al.. (1995). Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. Journal of Affective Disorders. 33(2). 67–75. 130 indexed citations
6.
Müller‐Oerlinghausen, B., B. Ahrens, Eva Grof, et al.. (1992). The effect of long‐term lithium treatment on the mortality of patients with manic‐depressive and schizoaffective illness*. Acta Psychiatrica Scandinavica. 86(3). 218–222. 116 indexed citations
7.
Schou, Mogens, H. E. Hansen, Kristian Korsgaard Thomsen, & Peter Vestergaard. (1989). Lithium Treatment in Aarhus. 2. Risk of Renal Failure and of Intoxication. Pharmacopsychiatry. 22(3). 101–103. 21 indexed citations
8.
Vestergaard, P. & Mogens Schou. (1989). Lithium Treatment in Aarhus. 1. Prevalence. Pharmacopsychiatry. 22(3). 99–100. 15 indexed citations
9.
Schou, Mogens. (1988). Lithium in Manic-Depressive Illness: Plusses, Pitfalls, and Perspectives. PubMed. 5. 140–146. 2 indexed citations
10.
Schou, Mogens. (1988). The integrated approach: On the significance of pharmacological and nonpharmacological factors when lithium prophylaxis fails. Acta Psychiatrica Scandinavica. 78(S345). 119–123. 3 indexed citations
11.
Schou, Mogens. (1988). Serum Lithium Monitoring of Prophylactic Treatment. Clinical Pharmacokinetics. 15(5). 283–286. 17 indexed citations
12.
Vestergaard, Per & Mogens Schou. (1987). Does Long-Term Lithium Treatment Induce Diabetes mellitus?. Neuropsychobiology. 17(3). 130–132. 34 indexed citations
13.
Schou, Mogens. (1986). Lithium longitudinally: An analysis of publication frequencies. Human Psychopharmacology Clinical and Experimental. 1(1). 51–55. 1 indexed citations
14.
Schou, Mogens. (1984). The author replies. Psychosomatics. 25(3). 242–242.
15.
Hansen, Hans Erik, E. B. Pedersen, Hans Ørskov, et al.. (1982). Plasma Arginine-Vasopressin, Renal-Concentrating Ability and Lithium Excretion in a Group of Patients on Long-Term Lithium Treatment. ˜The œNephron journals/Nephron journals. 32(2). 125–130. 10 indexed citations
16.
Schou, Mogens & Erik Strömgren. (1979). Origin, prevention, and treatment of affective disorders. Academic Press eBooks. 93 indexed citations
17.
Petersen, V. Posborg, S Hvidt, Klaus Thomsen, & Mogens Schou. (1974). Effect of Prolonged Thiazide Treatment on Renal Lithium Clearance. BMJ. 3(5924). 143–145. 59 indexed citations
18.
Schou, Mogens, A. Amdisen, Sigmund Jensen, & Thomas Olsén. (1968). Occurrence of Goitre during Lithium Treatment. BMJ. 3(5620). 710–713. 189 indexed citations
19.
Schou, Mogens, et al.. (1968). PROPHYLACTIC LITHIUM. The Lancet. 291(7557). 1419–1422. 26 indexed citations
20.
Amdisen, A., et al.. (1968). [Development of goiter during lithium treatment].. PubMed. 130(37). 1515–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026